Global Regulatory Strategy and Drug Development in Asia-Pacific, Latin America, and Other Emerging Markets
DIA is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This program is designated for 13 contact hours or 1.3 continuing education units (CEUs). Type of Activity: Knowledge; UAN: 0286-0000-17-014-L04-P
Participants must attend the entire program in order to be able to receive an ACPE statement of credit. No partial credit will be awarded.
ACPE Credit Requests MUST BE SUBMITTED by Monday, October 30, 2017
DIA is required by the Accreditation Council for Pharmacy Education (ACPE) to report pharmacy-requested CEUs through the CPE Monitor system.All ACPE-certified activity credit requests need to be submitted through DIA’s My Transcript within 45-days post activity.Pharmacists will need to provide their National Association of Boards of Pharmacy (NABP) e-Profile ID and date of birth (MMDD) to ensure the data is submitted to the ACPE and NABP properly. If you need to obtain your NABP e-Profile, please visit www.cpemonitor.net.
DIA has been accredited as an Authorized Provider by the International Association for Continuing Education and Training (IACET).
As an IACET Authorized Provider, DIA offers CEUs for its programs that qualify under the ANSI/IACET Standard. DIA is authorized by IACET to offer 1.3 CEUs for this program. Participants must attend the entire program in order to be able to receive an IACET statement of credit. No partial credit will be awarded.
This event is approved by the Regulatory Affairs Professionals Society for 12 RAC credits.
This program is part of DIA’s Certificate Program and is awarded the following.
• Regulatory Affairs Certificate Program: 8 Elective Units each
For more information go to DIAglobal.org/certificateprograms
It is DIA policy that anyone in a position to control the content of a continuing education activity must disclose to the program audience (1) any relevant financial relationships related to the content of their presentation and/or the educational activity, and (2) discussions of unlabeled or unapproved uses of drugs or medical devices.
This educational activity may include references to the use of products for indications not approved by the FDA. Opinions expressed with regard to unapproved uses of products are solely those of the faculty and are not endorsed by DIA or any of the manufacturers of products mentioned herein. Faculty for this educational activity was asked to disclose any discussion of unlabeled or unapproved uses of drugs or medical devices.
Disclosure statements are included with each instructor's biographical sketch.
|Name||Credit Type||Max Credits||CEU|
|Global Regulatory Strategy and Drug Development||Credit TypeACPE||Max Credits13.00||CEU1.300|
|Global Regulatory Strategy and Drug Development||Credit TypeIACET||Max Credits13.00||CEU1.300|